Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 21455300)

1.

Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model.

Holder BP, Simon P, Liao LE, Abed Y, Bouhy X, Beauchemin CA, Boivin G.

PLoS One. 2011 Mar 24;6(3):e14767. doi: 10.1371/journal.pone.0014767.

2.

Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.

Wong DD, Choy KT, Chan RW, Sia SF, Chiu HP, Cheung PP, Chan MC, Peiris JS, Yen HL.

J Virol. 2012 Oct;86(19):10558-70. doi: 10.1128/JVI.00985-12. Epub 2012 Jul 18.

3.

Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.

Abed Y, Pizzorno A, Bouhy X, Rhéaume C, Boivin G.

J Virol. 2014 Feb;88(3):1652-8. doi: 10.1128/JVI.02681-13. Epub 2013 Nov 20.

4.

Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses.

Abed Y, Pizzorno A, Bouhy X, Boivin G.

PLoS Pathog. 2011 Dec;7(12):e1002431. doi: 10.1371/journal.ppat.1002431. Epub 2011 Dec 8.

5.

Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.

Hurt AC, Nor'e SS, McCaw JM, Fryer HR, Mosse J, McLean AR, Barr IG.

J Virol. 2010 Sep;84(18):9427-38. doi: 10.1128/JVI.00373-10. Epub 2010 Jul 14.

6.

Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets.

Duan S, Boltz DA, Seiler P, Li J, Bragstad K, Nielsen LP, Webby RJ, Webster RG, Govorkova EA.

PLoS Pathog. 2010 Jul 29;6(7):e1001022. doi: 10.1371/journal.ppat.1001022.

7.

The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.

Pinilla LT, Holder BP, Abed Y, Boivin G, Beauchemin CA.

J Virol. 2012 Oct;86(19):10651-60. doi: 10.1128/JVI.07244-11. Epub 2012 Jul 25.

8.
9.

Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets.

Hamelin ME, Baz M, Bouhy X, Beaulieu E, Dubé K, Mallett C, Boivin G.

Antivir Ther. 2011;16(5):775-9. doi: 10.3851/IMP1794.

PMID:
21817200
10.

Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.

Seibert CW, Kaminski M, Philipp J, Rubbenstroth D, Albrecht RA, Schwalm F, Stertz S, Medina RA, Kochs G, García-Sastre A, Staeheli P, Palese P.

J Virol. 2010 Nov;84(21):11219-26. doi: 10.1128/JVI.01424-10. Epub 2010 Aug 25.

11.

Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.

Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Iwakuni O, Egashira K, Yamaji K, Kashiwagi S.

J Infect Chemother. 2012 Apr;18(2):180-6. doi: 10.1007/s10156-011-0314-2. Epub 2011 Dec 23.

PMID:
22193710
12.
13.

Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance.

Ottmann M, Duchamp MB, Casalegno JS, Frobert E, Moulès V, Ferraris O, Valette M, Escuret V, Lina B.

Antivir Ther. 2010;15(5):721-6. doi: 10.3851/IMP1576.

PMID:
20710053
14.

Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.

Eshaghi A, Bolotin S, Burton L, Low DE, Mazzulli T, Drews SJ.

J Clin Virol. 2009 Jun;45(2):142-5. doi: 10.1016/j.jcv.2009.04.010. Epub 2009 May 17.

PMID:
19451021
15.

Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.

Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr IG.

J Infect Dis. 2012 Jul 15;206(2):148-57. doi: 10.1093/infdis/jis337. Epub 2012 May 4.

16.

Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.

Wang B, Dwyer DE, Blyth CC, Soedjono M, Shi H, Kesson A, Ratnamohan M, McPhie K, Cunningham AL, Saksena NK.

Antiviral Res. 2010 Jul;87(1):16-21. doi: 10.1016/j.antiviral.2010.04.002. Epub 2010 Apr 10.

PMID:
20385168
17.

Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.

Nguyen HT, Trujillo AA, Sheu TG, Levine M, Mishin VP, Shaw M, Ades EW, Klimov AI, Fry AM, Gubareva LV.

Antiviral Res. 2012 Mar;93(3):381-6. doi: 10.1016/j.antiviral.2012.01.006. Epub 2012 Feb 7.

PMID:
22330888
18.

Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.

Zaraket H, Saito R, Suzuki Y, Baranovich T, Dapat C, Caperig-Dapat I, Suzuki H.

J Clin Microbiol. 2010 Apr;48(4):1085-92. doi: 10.1128/JCM.01532-09. Epub 2010 Feb 3.

19.

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.

Matsuzaki Y, Mizuta K, Aoki Y, Suto A, Abiko C, Sanjoh K, Sugawara K, Takashita E, Itagaki T, Katsushima Y, Ujike M, Obuchi M, Odagiri T, Tashiro M.

Virol J. 2010 Mar 5;7:53. doi: 10.1186/1743-422X-7-53.

20.

Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.

van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, Aron GI, Bestebroer TM, Koopmans M, Meijer A, Fouchier RA, Osterhaus AD, Boucher CA, Schutten M.

J Clin Virol. 2010 Jan;47(1):34-7. doi: 10.1016/j.jcv.2009.09.030. Epub 2009 Oct 25.

PMID:
19857993
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk